SCHEMBL1345237

SCHEMBL1345237

S=C=Nc1[c]cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3587331 0.77
Benzene SCHEMBL1970604 0.76 CYP3A4 (0.34)
SCHEMBL11776926 0.72 ALDH1A1 (0.32)
SCHEMBL8160672 0.72 ALDH1A1 (0.32)
SCHEMBL717495 0.69
SCHEMBL135781 0.69
SCHEMBL5469060 0.69
SCHEMBL11786338 0.69
SCHEMBL7048943 0.69
SCHEMBL11702690 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448861-A Ethyl naphthalene series liquid crystal monomer compound, and preparation method and application thereof 中节能万润股份有限公司 2022-12-09 CN claimed
CN-115093418-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2022-09-23 CN claimed
CN-115073476-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2022-09-20 CN claimed
US-10457685-B2 [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor HOFFMANN-LA ROCHE INC. (US) 2019-10-29 US claimed
US-20190127384-A1 [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR HOFFMANN-LA ROCHE INC. (US) 2019-05-02 US claimed
EP-3475282-A1 [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR H. Hoffnabb-La Roche Ag (CH) 2019-05-01 EP claimed
CN-109385267-A A kind of rare earth-phosphonic acids ultra-thin two-dimension material and its preparation method and application 复旦大学 2019-02-26 CN claimed
CN-109348716-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2019-02-15 CN claimed
WO-2017220517-A1 [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR F. HOFFMANN-LA ROCHE AG (CH) 2017-12-28 WO claimed
US-20120289681-A1 CONJUGATES OF CELL-PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND CORK (IE) 2012-11-15 US claimed
EP-2440252-A1 CONJUGATES OF CELL- PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT University College Cork, National University of Ireland, Cork (IE) 2012-04-18 EP claimed
WO-2010143172-A1 CONJUGATES OF CELL- PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND CORK (IE) 2010-12-16 WO claimed
EP-0529175-B1 Conjugates chelated with paramagnetic metals for targetting BRACCO INT BV (NL) 1995-08-09 EP claimed
US-5414114-A Method for making conjugate moieties capable of chelating paramagnetic metals and designed for coupling with a factor responsive to specific cellular marker sites BRACCO INTERNATIONAL B.V. (NL) 1995-05-09 US claimed
EP-0417870-B1 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy DIAGNOSTIKFORSCHUNG INST (DE) 1994-07-20 EP claimed
US-5202423-A Terpyridine derivatives WALLAC OY 1993-04-13 US claimed
EP-0529175-A1 Conjugates chelated with paramagnetic metals for targetting BRACCO International B.V. (NL) 1993-03-03 EP claimed
WO-1993001837-A1 CONJUGATED MOIETIES FOR CHELATING PARAMAGNETIC METALS SINTETICA S.A. (CH) 1993-02-04 WO claimed
JP-6100519-A None JP disclosed
US-3880871-A Isothiocyanophenyl substituted imidazoles SQUIBB & SONS INC 1975-04-29 US disclosed